← All trials
NCT07084298
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2025
- Primary completion
- May 31, 2026
- Completion date
- Jun 30, 2026
- First posted
- Jul 24, 2025
- Last posted
- Aug 6, 2025
- Enrollment
- 36
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of CalgaryLead sponsor
- University of CalgaryOfficial
- University of CalgarySponsor investigator
- Natural Sciences and Engineering Research Council, CanadaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.